Dr. Adam Luginbuhl
Otolaryngologist
5 Podcasts • 6 Cases on BackTable
Dr. Adam Luginbuhl is an Associate Professor of Otolaryngology Head and Neck Surgery at Thomas Jefferson University.
Learn from the experiences and expertise of Dr. Adam Luginbuhl and other leading voices in your specialty on the BackTable app.
Episode # 33 • 04 Nov 2025
Keynote-689: Implementation & Multidisciplinary Care for Immunotherapy in Head & Neck Cancer
When treating head and neck cancer, how can you tell the difference between true disease progression and pseudoprogression? In this episode of the BackTable Podcast, we discuss the practical implementation of the KEYNOTE-689 trial published in the New England Journal of Medicine, which demonstrated the benefit of adding neoadjuvant and adjuvant immunotherapy to standard head and neck cancer care. Our tumor board panel includes Dr. Mihir Patel, a head and neck surgeon from UNC Chapel Hill, Dr. Siddharth Sheth, a head and neck medical oncologist from UNC, Dr. Jennifer Johnson, a professor of medical oncology and otolaryngology at Sidney Kimmel Comprehensive Cancer Center, and Dr. Adam Luginbuhl, a head and neck surgical oncologist at Thomas Jefferson University.
More from Dr. Adam Luginbuhl
Loading recent podcasts…
ENT Case
Oct 28, 2025
HNC: T2N3 Primary Low Volume Head & Neck Squamous Cell Carcinoma
with Dr. X, Dr. Y, Dr. Z
Tumor Board Case
Oct 28, 2025
HNC: T3N0 Anterior Larynx Cancer with Erosion of Thyroid Cartilage Inner Table
with Dr. Dylan Roden and Dr. Adam Luginbuhl
Tumor Board Case
Oct 28, 2025
HNC: T4N2bM0 High Volume Primary Locally Advanced Head & Neck Squamous Cell Carcinoma
with Dr. Dylan Roden and Dr. Adam Luginbuhl
Tumor Board Case
Oct 28, 2025
HNC: T2N3 Primary Low Volume Head & Neck Squamous Cell Carcinoma
with Dr. Dylan Roden and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
HNC: T3N0 Anterior Larynx Cancer with Erosion of Thyroid Cartilage Inner Table
with Dr. X, Dr. Y, Dr. Z
ENT Case
Oct 28, 2025
HNC: T4N2bM0 High Volume Primary Locally Advanced Head & Neck Squamous Cell Carcinoma
with Dr. X, Dr. Y, Dr. Z
About
Dr. Luginbuhl is at the cutting edge of research bridging the gap of new immunotheraputic options, radioactive isotopes and surgery to offer a broad array of clinical trials and treatment options for head and neck cancer. His recent work with CDDO compounds in the laboratory have resulted in preventing some of the profound side effects experienced in radiation therapy.
Additionally he is deeply involved in Haitian mission work, taking 3-4 trips/year. He and his partners have performed the first free tissue transfer and continue to operate regularly in 2 different hospitals. He is leading a coalition to bring oncologic care to Haiti through radiation and chemotherapy.
Visit Jefferson Health to learn more about Dr. Adam Luginbuhl.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.